| Zacks Company Profile for Revvity Inc. (RVTY : NYSE) |
|
|
| |
| • Company Description |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Number of Employees: 11,000 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $96.03 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 1,570,986 shares |
| Shares Outstanding: 113.38 (millions) |
| Market Capitalization: $10,887.50 (millions) |
| Beta: 1.07 |
| 52 Week High: $120.39 |
| 52 Week Low: $81.36 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
-16.73% |
-15.42% |
| 12 Week |
2.14% |
-2.31% |
| Year To Date |
-0.74% |
-1.04% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
77 4TH AVENUE
-
WALTHAM,MA 02451
USA |
ph: 781-663-6900
fax: 781-663-5985 |
ir@revvity.com |
http://www.revvity.com |
|
|
| |
| • General Corporate Information |
Officers
Prahlad Singh - President and Chief Executive Officer
Maxwell Krakowiak - Senior Vice President and Chief Financial Officer
Anita Gonzales - Vice President and Controller
Peter Barrett - Director
Samuel R. Chapin - Director
|
|
Peer Information
Revvity Inc. (CHCR)
Revvity Inc. (ESRX)
Revvity Inc. (MYDP)
Revvity Inc. (COR)
Revvity Inc. (GBCS)
Revvity Inc. (LAXAF)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 714046109
SIC: 3826
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 12/01/25
Next Expected EPS Date: 04/27/26
|
|
Share - Related Items
Shares Outstanding: 113.38
Most Recent Split Date: 6.00 (2.00:1)
Beta: 1.07
Market Capitalization: $10,887.50 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.29% |
| Current Fiscal Quarter EPS Consensus Estimate: $1.03 |
Indicated Annual Dividend: $0.28 |
| Current Fiscal Year EPS Consensus Estimate: $5.41 |
Payout Ratio: 0.06 |
| Number of Estimates in the Fiscal Year Consensus: 7.00 |
Change In Payout Ratio: 0.01 |
| Estmated Long-Term EPS Growth Rate: 8.71% |
Last Dividend Paid: 01/16/2026 - $0.07 |
| Next EPS Report Date: 04/27/26 |
|
|
|
| |
